Form 4: Vanda Pharmaceuticals SVP Gunther Birznieks Sells Shares to Cover Tax Obligations

Gunther Birznieks, SVP of Business Development at Vanda Pharmaceuticals, sold shares of common stock on March 4th and 5th, 2024, to cover tax obligations related to the vesting of Restricted Stock Units (RSUs).

Summary

• Gunther Birznieks, SVP of Business Development at Vanda Pharmaceuticals, filed a Form 4 detailing changes in beneficial ownership.
• On March 4, 2024, Birznieks sold 8,727 shares of Vanda Pharmaceuticals common stock at a weighted average price of $4.2964.
• The shares were sold to satisfy tax obligations related to the acquisition of shares from vested RSUs.
• On March 5, 2024, Birznieks sold 8,684 shares of Vanda Pharmaceuticals common stock at a weighted average price of $4.1322.
• Following these transactions, Birznieks directly owns 313,569 shares of Vanda Pharmaceuticals common stock.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to stock sales for tax purposes, which is a neutral event.

Industry Context

Sales of shares to cover tax obligations upon RSU vesting are a common practice among company executives and do not necessarily indicate a negative outlook on the company's future.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.

Key Dates